Demissie Alemayehu of Pfizer and David Madigan of Northeastern University

The early registration deadline of April 30 is approaching for AIPM 2023—a platform for statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine; foster collaboration among industry, academia, regulatory agencies, and professional associations; and propose recommendations with policy implications for proper implementation of AI in promoting public health.

The theme of this year’s conference is “AI and Causality,” and Nobel laureate Guido Imbens of Stanford University is the keynote speaker.

The one-day symposium is scheduled for June 5 at the Portland Ocean Gateway in Portland, Maine.

Learn more about the symposium, which can be attended in person or virtually.